Predictive Model for Mild Autonomous Cortisol Secretion in Patients Evaluated in Artificial Intelligence-Driven Adrenal Incidentaloma Clinic
Clinical Snapshot
PICO Framework
| P — Population | Patients with adrenal incidentalomas evaluated in specialist clinic (n=397, mean age 62.3 years, 55% female) |
| I — Intervention | LASSO regression and random forest predictive models using clinical and radiological parameters |
| C — Comparator | Low-dose dexamethasone suppression test (reference standard) |
| O — Outcomes | Discrimination between mild autonomous cortisol secretion (MACS) and nonfunctional adrenal incidentalomas (NFAI) |
Bottom Line
This study developed predictive models to distinguish mild autonomous cortisol secretion from nonfunctional adrenal incidentalomas using clinical and radiological parameters. The random forest model achieved moderate discrimination (AUC 0.736) with 65% sensitivity and 76% specificity. While promising as a screening tool, the moderate accuracy limits immediate clinical adoption as a replacement for dexamethasone suppression testing. Key predictive factors included BMI, posterior adiposity index, and antihypertensive medication use. The retrospective single-centre design and lack of external validation limit generalisability. Further prospective validation studies with confidence intervals and cost-effectiveness analysis are needed before clinical implementation. The approach may be most valuable as a triage tool to prioritise patients for formal biochemical testing rather than definitive diagnosis.
Key Findings
P Value: Not reported
Effect Size: AUC 0.686 (LASSO) and 0.736 (random forest)
Primary Outcome: Discrimination between MACS and NFAI using predictive models
Nnt Or Sensitivity: Random forest: 64.7% sensitivity, 75.8% specificity, 72% accuracy
Confidence Interval: Not reported
Clinical Application
Requires clinical and radiological data collection, computational resources for model implementation Could complement current RACGP and Endocrine Society guidelines for adrenal incidentaloma evaluation, potentially reducing unnecessary dexamethasone suppression tests Patients with adrenal incidentalomas in specialist endocrine or surgical clinics
Abstract
BACKGROUND: Mild autonomous cortisol secretion (MACS) is present in approximately 20% to 50% of adrenal incidentalomas. These patients do not exhibit the clinical manifestations of overt Cushing's syndrome, and differentiation from nonfunctional adrenal incidentalomas (NFAI) is typically made after a low-dose dexamethasone suppression test. The objective of this study was to develop predictive models to distinguish MACS from NFAI using clinical and radiological parameters. STUDY DESIGN: This retrospective study included patients evaluated in an adrenal incidentaloma clinic between February 2022 and August 2024 who were diagnosed with either NFAI or MACS. Demographic characteristics, medical and medication history, and radiological features were collected. Patients were randomly divided into training and test cohorts in a 3:1 ratio. Predictive models for MACS were developed using Least Absolute Shrinkage and Selection Operator (LASSO) regression and random forest (RF) algorithms. RESULTS: A total of 397 patients were included, with 297 allocated to the training set and the remaining 100 to the test set. The mean age was 62.3 years, and 55% of participants (n = 220) were women. MACS was present in 34% of the study population (n = 136). The most influential predictive factors of MACS were BMI, Posterior Adiposity Index, and the number of antihypertensive medications. The LASSO and RF models achieved discrimination with area under the curve values of 0.686 and 0.736, respectively. At Youden Index thresholds balancing sensitivity and selectivity, the LASSO model had 58.8% sensitivity, 75.8% specificity, and 70% accuracy, whereas the RF model had 64.7% sensitivity, 75.8% specificity, and 72% accuracy. CONCLUSIONS: Predictive models incorporating clinical and radiological characteristics offer a promising approach for distinguishing MACS from NFAI in patients with adrenal incidentalomas.
References
- 1.Kostek, M., McLeod, C., Kasmirski, J., Negrete, H., Tridandapani, S., Cochran, M., Osborne, J. D., Gillis, A., Chen, H., & Lindeman, B. (2026). Predictive model for mild autonomous cortisol secretion in patients evaluated in artificial intelligence-driven adrenal incidentaloma clinic. Journal of the American College of Surgeons. https://doi.org/10.1097/XCS.0000000000001827
Related Research
European journal of radiology
A CT-based deep learning model to differentiate between benign and malignant adrenal lesions
3 Aug 2026
Journal of chemical information and modeling
A Unified Molecular Graph and Protein Language Model Framework for Predicting Human Drug-Hormone Receptor Interactions with Structure-Aware Validation
28 July 2026
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Differential effects of hormone therapy formulations on Parkinson's disease risk: a systematic review and meta-analysis
23 July 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service